Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications - PubMed (original) (raw)

Review

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

M Brownlee et al. N Engl J Med. 1988.

No abstract available

PubMed Disclaimer

Similar articles

• [Advanced glycosylation in diabetes mellitus. Occurrence of late complications].
  Esteves MC, Gonçalves AM, Caldeira JL. Esteves MC, et al. Acta Med Port. 2001 Jul-Aug;14(4):409-12. Acta Med Port. 2001. PMID: 11762182 Review. Portuguese.
• The pathological implications of protein glycation.
  Brownlee M. Brownlee M. Clin Invest Med. 1995 Aug;18(4):275-81. Clin Invest Med. 1995. PMID: 8549013 Review.
• Glycated proteins in diabetes.
  Furth AJ. Furth AJ. Br J Biomed Sci. 1997 Sep;54(3):192-200. Br J Biomed Sci. 1997. PMID: 9499597 Review.
• Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
  Friedman EA. Friedman EA. Diabetes Care. 1999 Mar;22 Suppl 2:B65-71. Diabetes Care. 1999. PMID: 10097902 Review.
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
  Vlassara H, Bucala R, Striker L. Vlassara H, et al. Lab Invest. 1994 Feb;70(2):138-51. Lab Invest. 1994. PMID: 8139257 Review. No abstract available.

Cited by

• Subcutaneous advanced glycation end products, cardiovascular risk factors and vascular health during childhood development in a Swiss population.
  Hauser C, Lona G, Köchli S, Streese L, Infanger D, Faude O, Hanssen H. Hauser C, et al. Front Physiol. 2024 Jul 19;15:1371618. doi: 10.3389/fphys.2024.1371618. eCollection 2024. Front Physiol. 2024. PMID: 39100277 Free PMC article.
• Combination therapy is it in the future for successfully treating peripheral diabetic neuropathy?
  Yorek M. Yorek M. Front Endocrinol (Lausanne). 2024 May 15;15:1357859. doi: 10.3389/fendo.2024.1357859. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38812811 Free PMC article. Review.
• Hyperglycaemia Aggravates Oxidised Low-Density Lipoprotein-Induced Schwann Cell Death via Hyperactivation of Toll-like Receptor 4.
  Nihei W, Kato A, Himeno T, Kondo M, Nakamura J, Kamiya H, Sango K, Kato K. Nihei W, et al. Neurol Int. 2024 Mar 19;16(2):370-379. doi: 10.3390/neurolint16020027. Neurol Int. 2024. PMID: 38525707 Free PMC article.
• Metabolic memory: mechanisms and diseases.
  Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung WK, Wang Q. Dong H, et al. Signal Transduct Target Ther. 2024 Feb 28;9(1):38. doi: 10.1038/s41392-024-01755-x. Signal Transduct Target Ther. 2024. PMID: 38413567 Free PMC article. Review.
• Total serum pentosidine quantification using liquid chromatography-tandem mass spectrometry.
  Blencowe LA, Božović A, Wong E, Kulasingam V, Cheung AM. Blencowe LA, et al. Bone Rep. 2024 Jan 17;20:101737. doi: 10.1016/j.bonr.2024.101737. eCollection 2024 Mar. Bone Rep. 2024. PMID: 38317648 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information